Medical Condition

immune sensitive tumor

Total Trials

1

Recruiting Now

1

Trial Phases

Phase 1

ClinicalMetric aggregates all active clinical trials for immune sensitive tumor from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

Recruiting trials — currently enrolling participants, with eligibility criteria
Phase 1–4 studies — from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary for every trial listing

NCT06952010 Phase 1

Recruiting

A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors